375 related articles for article (PubMed ID: 22294034)
1. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
2. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo.
Dong X; Qu W; Ma S; Zhu Z; Zheng C; He A; Karlsson A; Xu K; Zheng X
Cancer Lett; 2013 Jan; 328(1):95-103. PubMed ID: 23000515
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo.
Tang M; Zu C; He A; Wang W; Chen B; Zheng X
Drug Des Devel Ther; 2015; 9():3301-12. PubMed ID: 26203222
[TBL] [Abstract][Full Text] [Related]
4. Conditionally replicating adenovirus SG500-expressed mutant Dm-dNK gene for breast cancer therapy.
Qu W; Zhu Z; Zhao L; He A; Zheng X
Int J Oncol; 2012 Dec; 41(6):2175-83. PubMed ID: 23064407
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of adenovirus- and lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase on Bcap37 breast cancer cells.
Zhang N; Dong X; Sun Y; Cai X; Zheng C; He A; Xu K; Zheng X
Oncol Rep; 2013 Mar; 29(3):960-6. PubMed ID: 23254508
[TBL] [Abstract][Full Text] [Related]
6. Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.
Wang Q; Yang M; Zhang Y; Zhong L; Zheng X
Curr Gene Ther; 2019; 19(1):54-65. PubMed ID: 30848201
[TBL] [Abstract][Full Text] [Related]
7. Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase.
Zhu Z; Mao L; Zhao L; Sun Z; Wang Z; Xu H; Zheng X
Cancer Biol Ther; 2011 May; 11(10):874-82. PubMed ID: 21383545
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-mediated Drosophila melanogaster multisubstrate deoxyribonucleoside kinase gene therapy of gastric cancer cells in vitro and in vivo.
Zhu Z; Zhao L; He A; Huang B; Karlsson A; Xu H; Zheng X
Anticancer Res; 2010 Jul; 30(7):2641-9. PubMed ID: 20682993
[TBL] [Abstract][Full Text] [Related]
9. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
10. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
11. The multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells.
Ma S; Zhao L; Zhu Z; Liu Q; Xu H; Johansson M; Karlsson A; Zheng X
J Gene Med; 2011 Jun; 13(6):305-11. PubMed ID: 21674733
[TBL] [Abstract][Full Text] [Related]
12. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
Zhang ZL; Zou WG; Luo CX; Li BH; Wang JH; Sun LY; Qian QJ; Liu XY
Cell Res; 2003 Dec; 13(6):481-9. PubMed ID: 14728805
[TBL] [Abstract][Full Text] [Related]
13. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
14. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
Liu XY; Qiu SB; Zou WG; Pei ZF; Gu JF; Luo CX; Ruan HM; Chen Y; Qi YP; Qian C
Mol Ther; 2005 Apr; 11(4):531-41. PubMed ID: 15771956
[TBL] [Abstract][Full Text] [Related]
15. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
16. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol.
Zheng X; Johansson M; Karlsson A
Biochem Biophys Res Commun; 2001 Nov; 289(1):229-33. PubMed ID: 11708804
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
19. Potent anticancer effects of lentivirus encoding a Drosophila melanogaster deoxyribonucleoside kinase mutant combined with brivudine.
Zhang NQ; Zhao L; Ma S; Gu M; Zheng XY
Asian Pac J Cancer Prev; 2012; 13(5):2121-7. PubMed ID: 22901180
[TBL] [Abstract][Full Text] [Related]
20. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
